Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 96.03M | 99.36M | 75.80M | 141.12M | 137.39M | 95.36M |
Gross Profit | 16.50M | 23.84M | 13.32M | 52.12M | 47.41M | 30.27M |
EBITDA | -8.55M | -338.00K | -8.78M | 30.12M | 25.10M | 11.63M |
Net Income | -18.34M | -11.62M | -17.88M | 15.81M | 14.57M | 3.24M |
Balance Sheet | ||||||
Total Assets | 333.48M | 339.31M | 358.70M | 370.07M | 332.44M | 298.86M |
Cash, Cash Equivalents and Short-Term Investments | 31.58M | 22.83M | 39.89M | 44.29M | 42.18M | 72.84M |
Total Debt | 54.91M | 49.78M | 55.73M | 48.88M | 16.54M | 13.23M |
Total Liabilities | 87.31M | 84.41M | 89.56M | 80.33M | 52.21M | 43.33M |
Stockholders Equity | 185.04M | 192.77M | 203.99M | 221.61M | 211.53M | 192.62M |
Cash Flow | ||||||
Free Cash Flow | -8.54M | -17.88M | -7.07M | -37.23M | -32.95M | -13.99M |
Operating Cash Flow | -6.65M | -12.11M | 3.40M | -8.77M | -3.31M | 5.87M |
Investing Cash Flow | -1.32M | -4.45M | -2.60M | -25.22M | -38.81M | -16.42M |
Financing Cash Flow | 4.35M | -536.00K | 8.61M | 38.03M | 5.72M | 52.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
55 Neutral | $64.56M | 40.38 | -47.90% | ― | -16.52% | -46.13% | |
52 Neutral | $56.55M | ― | -2911.20% | ― | -47.93% | -37.78% | |
50 Neutral | AU$1.62B | 3.22 | -31.35% | 3.51% | 16.14% | -6.73% | |
49 Neutral | $109.09M | ― | -36.97% | ― | 6.14% | 1.71% | |
49 Neutral | $93.49M | ― | -12.56% | ― | -2.63% | -78.34% | |
47 Neutral | $74.24M | ― | 17.45% | ― | 94.76% | -146.39% | |
44 Neutral | $109.84M | ― | 1716.04% | ― | ― | ― |
AXT, Inc. recently appointed Leonard J. Leblanc to its Board of Directors, filling a vacancy left by the passing of Ms. Christine Russell. Mr. Leblanc, who has a rich history with the company and extensive experience in finance and corporate governance, will serve as a Class III director until July 2027. His familiarity with AXT’s operations and strategic needs is seen as crucial during this critical period. Additionally, Jesse Chen has been appointed as the Chair of the Audit Committee, bringing his expertise as an ‘audit committee financial expert’ to the role.
The most recent analyst rating on (AXTI) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.
On July 14, 2025, AXT, Inc. informed Nasdaq that they were not compliant with Nasdaq Listing Rule 5605(c)(2)(A) due to the passing of Ms. Christine Russell, which left their Audit Committee with only two independent directors instead of the required three. Nasdaq has granted AXT a cure period to regain compliance by either their next annual meeting or July 11, 2026, whichever comes first. AXT plans to appoint a new independent director to meet the compliance requirements before the deadline.
The most recent analyst rating on (AXTI) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.
AXT, Inc. announced the passing of Ms. Christine Russell, a member of its Board of Directors, on July 11, 2025. Ms. Russell, who joined the board in December 2019, was a key figure in the company’s governance, serving as Chair of the Audit Committee and participating in other committees. Her passing has left the company temporarily non-compliant with Nasdaq’s requirement for a minimum of three independent directors on the Audit Committee. AXT has until July 11, 2026, to regain compliance and is actively seeking a new independent director to fill the vacancy.
The most recent analyst rating on (AXTI) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.
On July 9, 2025, AXT, Inc. announced a preliminary revenue range for the second quarter of 2025, expecting revenues between $17.5 and $18 million, which is below the previously guided $20 to $22 million. This shortfall is attributed to slower issuance of export control permits for gallium arsenide products and weaker demand in China. Despite these challenges, AXT reported increased AI-related demand for indium phosphide in China and received its first export control permits for indium phosphide late in the quarter. The company remains focused on improving gross margins, expecting them to be in the high single digits for Q2 2025.
The most recent analyst rating on (AXTI) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.
On June 11, 2025, Beijing Tongmei Xtal Technology, a subsidiary of AXT, Inc., received its initial export permits from the Ministry of Commerce of the People’s Republic of China to resume shipping indium phosphide substrates to certain customers. This development follows the export controls imposed on February 4, 2025, by Chinese authorities on materials including indium, impacting the company’s operations and market positioning.
The most recent analyst rating on (AXTI) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.
On May 15, 2025, AXT held its Annual Meeting of Stockholders, where 69% of the total shares entitled to vote were represented. During the meeting, Christine Russell was elected as a Class III director for a three-year term, the executive compensation was approved on an advisory basis, the 2025 Equity Incentive Plan was approved, and BPM LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (AXTI) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.